Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹946.00
Market cap: ₹1,115 Cr
Revenue (annual): ₹853.6 Cr
Net profit (annual): ₹36.99 Cr
P/E (TTM): 30.1×Sector 50.4×
Promoter holding: 70.95%
FII holding: 5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Dividend 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Sep 2026 18:29 IST NSE

SME to Main Board Migration

Remus Pharmaceuticals SME to Main Board Migration

Remus Pharmaceuticals' board approved the company's migration from the NSE SME Emerge platform to the Main Board. It also announced a new subsidiary in the Dominican Republic.

Read the filing ↗